Literature DB >> 35145202

SLUG is a key regulator of epithelial-mesenchymal transition in pleomorphic adenoma.

Hyesung Kim1, Seung Bum Lee2, Jae Kyung Myung3, Jeong Hwan Park4, Eunsun Park1, Dong Il Kim5, Cheol Lee6, Younghoon Kim7, Chul-Min Park8, Min Bum Kim9, Gil Chai Lim10, Bogun Jang11.   

Abstract

The histogenesis of pleomorphic adenoma (PA) of the salivary glands remains controversial. PAs are characterized by the transition of epithelial cells to spindled mesenchymal cells, known as epithelial-mesenchymal transition (EMT). The present study aimed to identify a major EMT-inducing transcription factor (EMT-TF) in PAs. Real-time PCR analysis of SNAIL, SLUG, ZEB1, and TWIST1 demonstrated that only SLUG was significantly upregulated in normal salivary glands and PAs. Combined in situ hybridization for SLUG and multiplex immunohistochemistry for CK19 and P63 revealed that SLUG was specifically expressed in the myoepithelial cells of normal salivary glands. In PAs, SLUG was expressed in neoplastic myoepithelial cells and stromal cells but not in the luminal cells lining the inner layers of tumor glands. SLUG expression showed no correlation with PLAG1 expression, and in vitro experiments demonstrated that PLAG1 suppression in primary cultured PA cells or PLAG1 overexpression in HEK 293 T cells did not affect SLUG levels, indicating that PLAG1 was not involved in the upregulation of SLUG in PAs. The suppression of SLUG expression in cultured PA cells resulted in a morphology change to a less elongated shape and attenuated tumor growth. In addition, SLUG downregulation led to increased E-cadherin and decreased N-cadherin and vimentin expression levels along with decreased migratory activity in cultured PA cells. These findings suggest that SLUG is a major TF that can induce EMT in PAs. In summary, SLUG is specifically and highly expressed in the myoepithelial cells and stromal cells of PAs and is a key regulator of EMT in PAs.
© 2022. The Author(s), under exclusive licence to United States and Canadian Academy of Pathology.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35145202     DOI: 10.1038/s41374-022-00739-1

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  33 in total

Review 1.  Functional Histology of Salivary Gland Pleomorphic Adenoma: An Appraisal.

Authors:  Asterios Triantafyllou; Lester D R Thompson; Kenneth O Devaney; Diana Bell; Jennifer L Hunt; Alessandra Rinaldo; Vincent Vander Poorten; Alfio Ferlito
Journal:  Head Neck Pathol       Date:  2014-11-08

2.  Identification of NFIB as recurrent translocation partner gene of HMGIC in pleomorphic adenomas.

Authors:  J M Geurts; E F Schoenmakers; E Röijer; A K Aström; G Stenman; W J van de Ven
Journal:  Oncogene       Date:  1998-02-19       Impact factor: 9.867

Review 3.  Carcinoma ex pleomorphic adenoma: a comprehensive review of clinical, pathological and molecular data.

Authors:  Joyce Antony; Vinod Gopalan; Robert A Smith; Alfred K Y Lam
Journal:  Head Neck Pathol       Date:  2011-07-09

4.  HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma.

Authors:  Jeffrey K Mito; Vickie Y Jo; Simion I Chiosea; Paola Dal Cin; Jeffrey F Krane
Journal:  Histopathology       Date:  2017-07-05       Impact factor: 5.087

5.  Expression of reciprocal hybrid transcripts of HMGIC and FHIT in a pleomorphic adenoma of the parotid gland.

Authors:  J M Geurts; E F Schoenmakers; E Röijer; G Stenman; W J Van de Ven
Journal:  Cancer Res       Date:  1997-01-01       Impact factor: 12.701

6.  Promoter swapping between the genes for a novel zinc finger protein and beta-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations.

Authors:  K Kas; M L Voz; E Röijer; A K Aström; E Meyen; G Stenman; W J Van de Ven
Journal:  Nat Genet       Date:  1997-02       Impact factor: 38.330

7.  PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities.

Authors:  Nora Katabi; Bin Xu; Achim A Jungbluth; Lei Zhang; Sung Y Shao; Jason Lane; Ronald Ghossein; Cristina R Antonescu
Journal:  Histopathology       Date:  2017-10-19       Impact factor: 5.087

Review 8.  Defining the role of myoepithelium in salivary gland neoplasia.

Authors:  Adnan T Savera; Richard J Zarbo
Journal:  Adv Anat Pathol       Date:  2004-03       Impact factor: 3.875

9.  Epithelial-mesenchymal transdifferentiation and extracellular matrix gene expression in pleomorphic adenomas of the parotid salivary gland.

Authors:  T Aigner; D Neureiter; U Völker; J Belke; T Kirchner
Journal:  J Pathol       Date:  1998-10       Impact factor: 7.996

Review 10.  Salivary gland pleomorphic adenoma.

Authors:  William M Mendenhall; Charles M Mendenhall; John W Werning; Robert S Malyapa; Nancy P Mendenhall
Journal:  Am J Clin Oncol       Date:  2008-02       Impact factor: 2.339

View more
  2 in total

1.  Differential epithelial and stromal LGR5 expression in ovarian carcinogenesis.

Authors:  Hyesung Kim; Dong Hui Lee; Eunsun Park; Jae Kyung Myung; Jeong Hwan Park; Dong Il Kim; Se Ik Kim; Maria Lee; Younghoon Kim; Chul Min Park; Chang Lim Hyun; Young Hee Maeng; Cheol Lee; Bogun Jang
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

Review 2.  Pleomorphic Adenoma of the Salivary Glands and Epithelial-Mesenchymal Transition.

Authors:  Yuka Matsumiya-Matsumoto; Yoshihiro Morita; Narikazu Uzawa
Journal:  J Clin Med       Date:  2022-07-20       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.